Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Venetoclax Combined With Azacitidine in the Treatment of Acute Leukaemias of Ambiguous Lineage
NCT05901974Phase 2Recruiting
- Start
- Jul 2023
- Primary completion
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of venetoclax in acute leukemia of ambiguous lineage (ALAL). Started Jul 2023; status: recruiting.
02
Drugs
venetoclax
03
Conditions
acute leukemia of ambiguous lineage (ALAL)
Beyond the preview
Go deeper on NCT05901974.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05901974.